tiprankstipranks
Advertisement
Advertisement

BDRX Stock Latest News

Biodexa Pharmaceuticals Investors Reject Key Resolutions at June 30 AGM
Company AnnouncementsBiodexa Pharmaceuticals Investors Reject Key Resolutions at June 30 AGM
6d ago
6K
BDRX
Biodexa Raises $3.5 Million via Registered Offering, Private Placement and Warrant Inducement
PremiumCompany Announcements
Biodexa Raises $3.5 Million via Registered Offering, Private Placement and Warrant Inducement
7d ago
6K
BDRX
Biodexa Pharmaceuticals announces pricing of $3.5M registered offering
PremiumThe Fly
Biodexa Pharmaceuticals announces pricing of $3.5M registered offering
7d ago
BDRX
Biodexa Pharmaceuticals receives Health Canada approval for Serenta trial
PremiumThe Fly
Biodexa Pharmaceuticals receives Health Canada approval for Serenta trial
8d ago
BDRX
Biodexa Pharmaceuticals Adjourns AGM for Lack of Quorum, Reschedules to June 30
PremiumCompany Announcements
Biodexa Pharmaceuticals Adjourns AGM for Lack of Quorum, Reschedules to June 30
19d ago
6K
BDRX
Biodexa Pharmaceuticals Proposes Major Share Capital Reorganization Ahead of June AGM
PremiumCompany AnnouncementsBiodexa Pharmaceuticals Proposes Major Share Capital Reorganization Ahead of June AGM
2M ago
6K
BDRX
Upcoming Stock Splits This Week (April 6-10, 2026) – Stay Invested
Premium
Market News
Upcoming Stock Splits This Week (April 6-10, 2026) – Stay Invested
3M ago
CHR
SKK
Biodexa Pharmaceuticals PLC-ADR trading halted, news pending
Premium
The Fly
Biodexa Pharmaceuticals PLC-ADR trading halted, news pending
3M ago
BDRX
Biodexa Pharmaceuticals announces MTX240 manufacturing pact with Syngene
PremiumThe Fly
Biodexa Pharmaceuticals announces MTX240 manufacturing pact with Syngene
3M ago
BDRX
Biodexa, Tanner Pharma launch global early access program for FAP patients
PremiumThe Fly
Biodexa, Tanner Pharma launch global early access program for FAP patients
3M ago
BDRX
Biodexa Pharmaceuticals Posts 2025 Preliminary Results and Deepens GI Cancer-Focused Pipeline
PremiumCompany Announcements
Biodexa Pharmaceuticals Posts 2025 Preliminary Results and Deepens GI Cancer-Focused Pipeline
3M ago
6K
BDRX
Biodexa Pharmaceuticals management to meet with Maxim
PremiumThe Fly
Biodexa Pharmaceuticals management to meet with Maxim
4M ago
BDRX
Biodexa Pharmaceuticals Announces Reverse ADR Split to Support Nasdaq Compliance
PremiumCompany AnnouncementsBiodexa Pharmaceuticals Announces Reverse ADR Split to Support Nasdaq Compliance
4M ago
6K
BDRX
Biodexa Pharmaceuticals announces one-for-five reverse ADR split
Premium
The Fly
Biodexa Pharmaceuticals announces one-for-five reverse ADR split
4M ago
BDRX
Biodexa Pharmaceuticals supports Life’s a Polyp Foundation
Premium
The Fly
Biodexa Pharmaceuticals supports Life’s a Polyp Foundation
4M ago
BDRX
Biodexa Licenses Otsuka’s Phase 1‑Ready Molecular Glue MTX240 for GIST
PremiumCompany Announcements
Biodexa Licenses Otsuka’s Phase 1‑Ready Molecular Glue MTX240 for GIST
5M ago
6K
BDRX
Biodexa Pharmaceuticals announces exclusive license with Otsuka Pharmaceutical
PremiumThe Fly
Biodexa Pharmaceuticals announces exclusive license with Otsuka Pharmaceutical
5M ago
BDRX
Biodexa Pharmaceuticals Names Fiona Sharp CFO and Board Director
PremiumCompany Announcements
Biodexa Pharmaceuticals Names Fiona Sharp CFO and Board Director
6M ago
6K
BDRX
Biodexa Pharmaceuticals Promotes Fiona Sharp to CFO and Board Director
PremiumCompany Announcements
Biodexa Pharmaceuticals Promotes Fiona Sharp to CFO and Board Director
6M ago
6K
BDRX
Biodexa Pharmaceuticals promotes Fiona Sharp to CFO, secretary
PremiumThe FlyBiodexa Pharmaceuticals promotes Fiona Sharp to CFO, secretary
6M ago
BDRX
Biodexa Pharmaceuticals Prices $10 Million U.S. Public Offering to Fund Pipeline
Premium
Company Announcements
Biodexa Pharmaceuticals Prices $10 Million U.S. Public Offering to Fund Pipeline
7M ago
6K
BDRX
Biodexa Pharmaceuticals prices 157,000 units at $3.28 in public offering
Premium
The Fly
Biodexa Pharmaceuticals prices 157,000 units at $3.28 in public offering
7M ago
BDRX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >